维普中文期刊产品整合服务
63篇 您的检索式:作者名="Imig JD"
    题名 作者 年代 出处 被引量
1Obesity,insulin resistance,and renal function显示文摘Knight SF Imig JD 2007Microcirculation2007,14,:1
2Obesity,insulin resistance,and renal function显示文摘Knight SF Imig JD 2007Microcirculation2007,14,45:1
3Afferent arteriolar vasodilation to the sulfonimide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A 显示文摘Imig JD Inscho EW Deichmann PC 1999Hypertension1999,33,12:1
4Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice显示文摘Lee CR Imig JD Edin ML 2010FASEB J2010,24,10:1
5Normalization of the ovarian cancer microenvironment by SPARC显示文摘Said N Socha MJ Olearczyk JJ Elmarakby AA Imig JD MotamedK 2007Mol Cancer Res2007,5,:1
6ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin显示文摘Inscho EW Imig JD Cook AK 2005Br J Pharmacol2005,146,7:1
7Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats显示文摘Olearczyk JJ Hammock BD Imig JD 2009Clin Sci2009,116,1:1
8Epoxyeicosatrienoic acids, 20-hydroxyeico- satetraenoic acid, and renal microvascular function显示文摘Imig JD 2013Prostaglandins Other Lipid Mediat2013,1041,:1
9Eicosanoids and renal vascular function in diseases显示文摘Imig JD 2006Clin Sci (Lond)2006,111,1:1
10SPARC ameliorates ovarian cancer - associated inflammation 显示文摘Said NA Elmarakby AA Imig JD 2008Neoplasia2008,10,10:1
11Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors 显示文摘Imig JD 2006Cardiovasc Drug Rev2006,24,2:1
12Afferent arteriolar vasodilation to the sulfonimide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A显示文摘Imig JD Inscho EW Deichmann PC Reddy KM Falck JR 1999Hypertension1999,33,12:1
13TNF alpha inhibition reduces re nal injury in DOCA-salt hypertensive rats 显示文摘Elmarakby AA Quigley JE Imig JD 2008Am J Physiol Regul Integr Comp Physiol2008,294,1:1
14Purinoceptor-mediated calcium signaling in preglomerular smooth muscle cells 显示文摘Inscho EW LeBlanc EA Pham BT White SM Imig JD 1999Hypertension1999,33,12:1
15Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation 显示文摘Kim J Imig JD Yang J 2014Am J Physiol Renal Physiol2014,27,2:1
16Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases显示文摘Imig JD 2005Am J Physiol Renal Physiol2005,289,3:1
17Cytochrome P450 eico-sanoids and cerebral vascular function显示文摘Imig JD Simpkins AN Renic M 2011Expert Rev Mol Med2011,13,:1
18An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protec-tion in salt-sensitive hypertension显示文摘Imig JD Zhao X Zaharis CZ 2005Hypertension2005,46,4:1
19Intrarenal production of angiotensin Ⅱ 显示文摘 Imig JD Zou L 1997Semin Nephrol1997,17,:1
20Adaptation of the renal microcirculation to hypertension显示文摘Imig JD Inscho EW 2002Microcirculation2002,9,4:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费